Zimmer Biomet completed a public offering of €1.0 billion aggregate amount of senior notes. Our firm represented Zimmer Biomet as issuer’s counsel in the offering and sale of the senior notes, as well as the listing of the senior notes on the New York Stock Exchange.
The proceeds from the senior notes offering were used to purchase approximately $1.3 billion of certain series of Zimmer Biomet's outstanding senior notes in cash tender offers. Our firm also represented Zimmer Biomet in the cash tender offers.
